American College of Cardiology (ACC.25)
Chicago, Illinois
March 29 - March 31, 2025
Anumana is excited to be back at ACC! Connect with us at the conference to learn how ECG-AI™ can help you enhance the utility of standard 12-lead ECGs
Get a product demo at booth #9004
Enhance the Power of ECG with Anumana's ECG-AITM
Anuamna's ECG-AI elevates ECG analysis by harnessing deep learning using a vast real world data set, uncovering subtle and unknown signals, as well as complex interdependencies. This breakthrough technology helps clinicians to identify difficult to diagnose cardiac conditions earlier.
Learn how our FDA cleared ECG-AI LEF can help clinicians detect Low Left Ventricular Ejection Fraction here.
Clinically validated. Real-world performance.
4
FDA Breakthrough Device Designation
1
1 FDA Cleared ECG-AI algorithm
12+
Algorithms Under Development
3
Established Pharma Partnerships
75+
Peer Reviewed Publications on Neural Network of ECG-AI
@2025 anumana, Inc. All rights reserved.